Cochrane Abstracts
Drug treatment for facioscapulohumeral muscular dystrophy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Drug Treatment for Facioscapulohumeral Muscular Dystrophy." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437610/all/Drug_treatment_for_facioscapulohumeral_muscular_dystrophy.
Drug treatment for facioscapulohumeral muscular dystrophy. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437610/all/Drug_treatment_for_facioscapulohumeral_muscular_dystrophy. Accessed March 12, 2025.
Drug treatment for facioscapulohumeral muscular dystrophy. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437610/all/Drug_treatment_for_facioscapulohumeral_muscular_dystrophy
Drug Treatment for Facioscapulohumeral Muscular Dystrophy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437610/all/Drug_treatment_for_facioscapulohumeral_muscular_dystrophy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Drug treatment for facioscapulohumeral muscular dystrophy
ID - 437610
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437610/all/Drug_treatment_for_facioscapulohumeral_muscular_dystrophy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
